A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
LNA SANTE operates in the Medical - Care Facilities industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 871M | 871M | 799M | 767M | - | - |
| Net Income | 24M | 24M | 25M | 30M | 28M | 9.7M |
| EPS | $2.31 | $2.31 | $2.49 | $2.62 | $2.90 | $1.00 |
| Free Cash Flow | 119M | 119M | 106M | 109M | - | - |
| ROIC | 17.4% | 4.4% | 4.8% | 8.2% | 8.7% | 3.3% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 2.56 | 2.82 | 2.40 | - | - |
| Dividends/Share | $0.62 | $0.65 | $0.54 | $0.45 | $0.33 | $0.62 |
| Operating Income | 67M | 67M | 68M | 67M | 28M | 9.7M |
| Operating Margin | 7.7% | 7.7% | 8.6% | 8.8% | - | - |
| ROE | 7.0% | 7.1% | 7.9% | 10.3% | 11.6% | 4.4% |
| Shares Outstanding | 11M | 11M | 11M | 11M | 10M | 10M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | N/A | N/A | N/A | 767M | 799M | 871M | 871M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 24M | 9.7M | 28M | 67M | 68M | 67M | 67M |
| Op. Margin | N/A | N/A | N/A | 8.8% | 8.6% | 7.7% | 7.7% |
| Net Income | 24M | 9.7M | 28M | 30M | 25M | 24M | 24M |
| Net Margin | N/A | N/A | N/A | 3.9% | 3.2% | 2.7% | 2.7% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||
| ROIC | 8.3% | 3.3% | 8.7% | 8.2% | 4.8% | 4.4% | 17.4% |
| ROE | 11.0% | 4.4% | 11.6% | 10.3% | 7.9% | 7.1% | 7.0% |
| ROA | N/A | N/A | N/A | 1.9% | 1.6% | 1.4% | 1.4% |
| Cash Flow | |||||||
| Op. Cash Flow | 0 | 0 | 0 | 109M | 106M | 119M | 119M |
| Free Cash Flow | N/A | N/A | N/A | 109M | 106M | 119M | 119M |
| Owner Earnings | 0 | 0 | 0 | 109M | 106M | 119M | 119M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||
| Dividends Paid | 4.9M | 6.0M | 3.2M | 4.8M | 5.6M | 6.6M | 6.6M |
| Dividend Yield | 1.0% | 1.2% | 0.6% | 1.2% | 1.7% | 2.5% | 2.2% |
| Share Buybacks | 0 | 0 | 0 | 0 | 6.7M | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||
| Net Debt | N/A | N/A | N/A | 648M | 833M | 786M | -81M |
| Cash & Equiv. | N/A | N/A | N/A | 107M | 84M | 81M | 81M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | N/A | N/A | 2.40 | 2.82 | 2.56 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 220M | 225M | 263M | 315M | 325M | 339M | 339M |
| Total Assets | N/A | N/A | N/A | 1.6B | 1.6B | 1.7B | 1.7B |
| Total Liabilities | N/A | N/A | N/A | 1.3B | 1.3B | 1.3B | 1.3B |
| Intangibles | N/A | N/A | N/A | N/A | 459M | 477M | 477M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital | N/A | N/A | N/A | -187M | -22M | -41M | -41M |
| Current Assets | N/A | N/A | N/A | 336M | 362M | 404M | 404M |
| Current Liabilities | N/A | N/A | N/A | 523M | 384M | 445M | 445M |
| Per Share Data | |||||||
| EPS | 2.50 | 1.00 | 2.90 | 2.62 | 2.49 | 2.31 | 2.31 |
| Owner EPS | 0.00 | 0.00 | 0.00 | 10.15 | 9.88 | 11.14 | 11.14 |
| Book Value | 22.69 | 23.17 | 26.97 | 29.38 | 30.34 | 31.66 | 31.66 |
| Cash Flow/Share | N/A | N/A | N/A | 10.15 | 9.88 | 11.14 | 2.20 |
| Dividends/Share | 0.51 | 0.62 | 0.33 | 0.45 | 0.54 | 0.65 | 0.62 |
| Shares Out. | 9.7M | 9.7M | 9.8M | 10.7M | 10.7M | 10.7M | 10.7M |
| Valuation | |||||||
| P/E Ratio | 21.6 | 61.6 | 20.0 | 11.6 | 8.9 | 10.7 | 12.4 |
| P/FCF | N/A | N/A | N/A | 3.0 | 2.2 | 2.2 | 2.6 |
| EV/EBIT | N/A | N/A | N/A | 14.5 | 15.7 | 15.6 | 3.3 |
| Price/Book | 2.4 | 2.7 | 2.1 | 1.0 | 0.7 | 0.8 | 0.9 |
| Price/Sales | N/A | N/A | N/A | 0.4 | 0.3 | 0.3 | 0.4 |
| FCF Yield | N/A | N/A | N/A | 33.5% | 44.5% | 45.1% | 39.0% |
| Market Cap | 525M | 597M | 565M | 325M | 238M | 265M | 306M |
| Avg. Price | 52.29 | 53.13 | 59.28 | 36.36 | 29.67 | 24.80 | 28.60 |
| Year-End Price | 54.05 | 61.50 | 57.87 | 30.31 | 22.22 | 24.71 | 28.60 |
LNA SANTE passes 2 of 9 quality checks, indicating weak fundamentals.
LNA SANTE trades at 12.4x trailing earnings, compared to its 15-year median P/E of 15.8x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 2.6x vs a median of 2.2x. The company's 5-year average ROIC is 5.9%. Total shareholder yield (dividends) is 2.2%. At current prices, the estimated annualized return to fair value is +56.6%.
LNA SANTE (LNA-PA) has a current P/E ratio of 12.4, compared to its historical median P/E of 15.8. The stock is currently considered Fair based on its historical valuation range.
LNA SANTE (LNA-PA) has a 5-year average return on invested capital (ROIC) of 5.9%. This is below average and may indicate limited pricing power.
LNA SANTE (LNA-PA) has a market capitalization of $306M. It is classified as a small-cap stock.
Yes, LNA SANTE (LNA-PA) pays a dividend with a trailing twelve-month yield of 2.16%.
Based on historical P/E analysis, LNA SANTE (LNA-PA) appears fair. The current P/E of 12.4 is 21% below its historical median of 15.8. The estimated fair value CAGR (P/E method) is 3.1%.
LNA SANTE (LNA-PA) operates in the Medical - Care Facilities industry, within the Healthcare sector.
LNA SANTE (LNA-PA) reported annual revenue of $871 million in its most recent fiscal year, based on SEC EDGAR filings.
LNA SANTE (LNA-PA) has a net profit margin of 2.7%. This is a modest margin.
LNA SANTE (LNA-PA) generated $119 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
LNA SANTE (LNA-PA) has a debt-to-equity ratio of 2.56. This indicates higher leverage, which may increase financial risk.
LNA SANTE (LNA-PA) reported earnings per share (EPS) of $2.31 in its most recent fiscal year.
LNA SANTE (LNA-PA) has a return on equity (ROE) of 7.1%. This indicates moderate shareholder returns.
The Ledger Terminal provides 6 years of financial data for LNA SANTE (LNA-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
LNA SANTE (LNA-PA) has a book value per share of $31.66, based on its most recent annual SEC filing.